Get started
QUIDELORTHO CORPORATION COM USD0.001QUIDELORTHO CORPORATION COM USD0.001QUIDELORTHO CORPORATION COM USD0.001

QUIDELORTHO CORPORATION COM USD0.001

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

0A55 trade ideas

Quidel (NASDAQ: $QDEL) Looks Like A Deal Under The 0.786 Fib! 🧪Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide. It offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus, a POC products to detect infectious and inflammatory diseases and conditions of the eye. The company also provides Triage MeterPro, a portable testing platform that enables physicians to promote enhanced health outcomes, as well as the detection of certain drugs of abuse; Triage BNP test for use on Beckman Coulter lab analyzers; and Triage TOX drug screen, which provides results for the determination of the presence of drug and/or the major metabolites in urine. In addition, it offers traditional cell lines, specimen collection devices, media, and controls for use in laboratories that culture and test for various human viruses, including respiratory and herpes family viruses; and cell-based products comprising tubes, shell vials, and multi-well plates. Further, the company provides biomarkers, which include clinical and research products for the assessment of osteoporosis and the evaluation of bone resorption/formation; and enzyme linked immunosorbent assays and reagents for the detection of activation products. Additionally, it offers Lyra molecular real-time polymerase chain reaction assays; Solana, an amplification and detection system; and Virena, a wireless cellular data management and surveillance system The company markets its products through distributors and direct sales force for use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail and urgent care clinics, pharmacies, and wellness screening centers. Quidel Corporation was incorporated in 1979 and is headquartered in San Diego, California.
NASDAQ:QDELLong
by Bullishcharts
ShortBreakdown of all support lines. I expect a decline to $102. But you should be careful, it is possible to redeem and it will be a false-break. Entry with confirmation. ❤️ If you find this helpful and want more FREE forecasts in TradingView . . . . . Please show your support back, . . . . . . . . Hit the 👍 LIKE button, . . . . . . . . . . . Drop some feedback below in the comment! ❤️ Your Support is very much 🙏 appreciated!❤️ 💎 Want us to help you become a better Stock trader? Now, It's your turn! Be sure to leave a comment let us know how do you see this opportunity and forecast.
NASDAQ:QDELShort
by QuantumLabSignals
Quidel has a future! Worldwide opposition to vaccine mandates, booster shots every "x" months, negative test required upon arrival for travel. The unvaccinated have antibodies! One of the only stocks that benefits from calamity like this is QUIDEL. In short Quidel does everything related to covid testing including testing for antigens. At the start of the pandemic Quidel rose due to the evident need for covid testing. However, since achieving the highs in August 2020. The same time vaccines where announced and were first available to the high risk. This was also the same time it was in announced in the US that vaccines would be available shortly to the public. This stirred up a narrative that once the vaccines were here there would be no need for diagnostic equipment. Now look at us. 40% of the people don't want the vaccine, those with the vaccine still get covid, a new variant every couple months, a seemingly never ending line of boosters, etc. All these reasons are why testing equipment is even more needed. If you believe Covid will disappear soon, this is not the stock for you. Also, another risk is supply chain issues. If Quidel is not able to produce enough of their poduct expected sales will not be exceeded. Quidel's balance sheet and financial health are impeccable for a company in 2021. They only have around 100 million in debt and 550 million in cash. Additionally, "risky" debt such as convertible bonds and revolver debt they used to finance operations in the beginning stages of their company has been paid off. They are rolling In cash due to investors who believed in Quidel's mission and gave them money to sell testing equipment. That extra money was used to develop new/better tests. I also ike Quidel because they are a healthcare company a sector that does well in the latter part of the economic cycle. I would not be surprised if Quidel gets acquired either. 104 stop loss The TA on the chart is used for me to find pivot points and areas to use as stop losses and profit taking. My bullish bias comes from fundamental analysis. Thoughts? (I usually don't include financial analysis on TV) so for compliance reasons. I must say this not financial advice......
NASDAQ:QDELLong
by arama-nuggetrouble
5
Testing kits on Delta VariantFundamental Quidel: a manufacturer of diagnostic products, frequently rises or sinks in response to developments in the coronavirus pandemic, as a big part of their revenue comes from its COVID-19 testing kits. As the Delta Variant is worrying countries around the globe, QDEL will be interesting to watch. Technical Analysis As you can see in the weekly chart, the blue horizontal line which is approximately $150 was tested multiple times, is now also coinciding with the 50ema, which has worked well as support. A potential target could be in place, as there is still a downtrend from the Pfizer Vaccine initial news of 95% efficacy.
NASDAQ:QDEL
by dorfmanmaster
1
QDEL - Fantastic Retrace, Good Buy Perhaps Soon!Named one of Investopedia's Top Growth Stocks for May 2021, QDEL offers a good buying opportunity even at current prices. QDEL (www.wsj.com) has a low price target of $95 and a median price target of $167. I would think this a great buy at $80-95 with a sell at $140, which is the current resistance before a pop upwards is possible. This would take approximately 1.5-2 months to achieve. I'll be watching! www.investopedia.com
NASDAQ:QDEL
by Grandmaster76
2
QDEL (Quidel Corp) - Bullish QuarterQuidel Corp Quidel Corp. discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions that affect women's health throughout the phases of their lives including reproductive status, pregnancy management and osteoporosis. Quidel also provides point-of-care diagnostics for infectious diseases, including influenza A and B, strep throat, H. pylori infection, chlamydia and infectious mononucleosis. Analysis/Commentary Strong EPS and Sales Growth Y-on-Y Beaten down at the start of the quarter, as health stocks generally are punished Based on the study of the previous quarterly earnings reports and subsequent price moves: - Current quarter has given price move to the down side - Buy at oversold position on RSI (now) - Expectation for the price to move to TARGET RANGE during the financial quarter - Trailing stop-loss on price above TARGET PRICE GOOD LUCK. DO YOUR OWN RESEARCH!
NASDAQ:QDELLong
by kennzo
Quidel CorporationQuidel (QDEL) is cheap for me now. The market somewhat exaggerated its sale. This company has a lot to offer even after the COVID crisis. Are there any other positive news and their balance sheet? Research yourself, strong company! Iam in at 125.5 and waitin for some good premium, expect a mild pump on Monday, but I'm waiting for at least a 50-100 % profit, will see. I will sell when I find the company expensive, it may happen sooner or never. I have time and you?
NASDAQ:QDELLong
by liborbtc
2
$ QDEL - Bullish signals before Earnings reportIt has been growing dramatically as part of the pandemic, which is not surprising. What I see now. The paper is moving in a downward channel (highlighted in blue). In February it broke through the uptrend line that started in March 20. And now it is trading closer to the lower boundary of the channel. The maximum that the paper can go down, I see at $104-$105. There passes the border of the channel and the level of resistance. But in the current situation there are some positive signals that in such a descending trend you may try to pick up the paper. 1. I see the formation of a downward wedge (time period from mid-February to the current date). The volatility of the paper is decreasing. This can be seen on the highest indicator. 2. the MACD indicator is in a negative zone, while the indicator line is above the signal line. 3. RSI begins to grow and is already above 50 on the 4-hour timeframe. 4. Short Interest in the paper is at 8.54%. 5. The average analyst Target for the next year $226.5, which gives the upside of about 71.32% of yesterday's closing price. 6. P/E for the company is now 7.2 and it looks undervalued compared to many other companies. 7. On Friday 2/04/21, the company announced that it had received an Emergency Use Permit from the FDA for SOFIA SARS FIA ANTIGEN FOR COVID-19 TESTING and Quidel has also been selected as the "official diagnostic partner" of the San Diego Padres Major League Baseball franchise. Potential targets in possible developments: Negative scenario. 1. Hike to a downtrend to the 115 level and take out stops, 2. The subsequent decline to the level of 105. There it is possible to take the long term. Positive scenario. 1. an aggressive stop at 125 (-5.5%), at a higher risk, a stop just below the last local low at 119.3 (-10.3%). 2. On the upside exit of their wedge, the first upside target is $175 (+32.3%), the second target $192.4 (+45.5% gap level) and the third target $207.8 (+57.1% gap closure level) and potentially a downtrend resistance level. The angle of the rising trend in the last 2 times was 71 degrees. The current growth from the lows is still going with the same slope. And if it continues, the deadline for reaching the third target is mid-May. And the company has another quarterly report on 05/13/21. This view is my opinion and is not investment recommendation.
NASDAQ:QDELLong
by kovpups
4
Buy $QDEL - NRPicks 21 MarQuidel Corporation develops, manufactures and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases and toxicology worldwide. The company during 2020 benefited greatly from the pandemic thanks to its Covid-19 QuickVue test that recently received FDA authorization to apply it from house to home. The company is optimistic about the Biden Administration's urgent and comprehensive approach to bringing the benefits of rapid, routine, and equitable coronavirus testing to U.S. classrooms, under-neglected communities, and rural areas. - Sales Y/Y 210% - EBITDA Y/Y 628% - Net income Y/Y 1010% Technical: - Low RSI levels - Bounce on MA100 - Support $128
NASDAQ:QDELLong
by NewroadTrader
QDEL is a strong buyQuidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide. Why I'm buying right now: Price target is from low 165.00 to high 341.00 2019 earnings - 72.92 M -> 2020 earnings - 810.29 M = 1111.2 % Testing is increasing again and we are still above 1 M tests per day Covid situation in world is indicating third global wave with Europe countries leading it
NASDAQ:QDELLong
by TulipMania1636
2